Overview of CLL12 trial of ibrutinib aiming to delay chemoimmunotherapy
The CLL2-BAG trial: can CLL patients safely cease treatment after remission?
Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL
Era of personalized therapy in CLL
Clinical trials investigating venetoclax combinations for AML